ARRS competitors

James L. Madara, MD, serves as the CEO and executive vice president of the American Medical Association, the nation’s largest physician organization. He holds the academic title of adjunct professor of pathology at Northwestern University. Since taking the reins of the AMA in 2011, Dr. Madara has helped sculpt the organization’s visionary long-term strategic plan. As an extension of this vision, he now also serves as chairman of Health2047 Inc., an independent, design-driven innovation firm based in San Francisco whose mission is to help advance the AMA’s goal of improving the health of the nation. Prior to arriving at the AMA, Dr. Madara spent the first 22 years of his career at Harvard Medical School, receiving both clinical and research training, serving as a tenured professor and as director of the NIH-sponsored Harvard Digestive Diseases Center. Following 5 years as chair of pathology at Emory, Dr. Madara served as dean of the medical school and CEO of the hospitals at the University of Chicago, bringing together the university’s biomedical research, teaching and clinical activities. While there, he oversaw the renewal of the institution’s biomedical campus and engineered significant new affiliations with community hospitals, teaching hospital systems, community clinics and national research organizations. Dr. Madara also served as senior advisor with Leavitt Partners, an innovative health care consulting and private-equity firm founded by former Secretary of Health and Human Services, Mike Leavitt. Having published more than 200 original papers and chapters, Dr. Madara has received both national and international awards, and served as editor-in-chief of the American Journal of Pathology and as president of the American Board of Pathology. In addition to Modern Healthcare consistently naming him as one of the nation’s 50 most influential physician executives, as well as one of the nation’s 100 most influential people in health care, he is a past recipient of a prestigious MERIT Award from the National Institutes of Health. He received the 2011 Davenport Award for lifetime achievement in gastrointestinal disease from the American Physiological Society and the 2011 Mentoring Award for lifetime achievement from the American Gastroenterological Society. Dr. Madara is an elected member of both the American Society of Clinical Investigation and the Association of American Physicians. He also co-chairs the Value Incentives and Systems Innovation Collaborative of the National Academy of Medicine (NAM), and is a member of NAM’s Leadership Consortium for Value & Science-Driven Health Care. Dr. Madara and his wife Vicki have 2 children, Max and Alexis.

Stefano Bertuzzi is a Chief Executive Officer at American Society for Microbiology and is based in Washington, District of Columbia. He has worked as Director, Office of Science Policy, Planning and Communications at National Institute of Mental Health (NIMH); Research Associate at Salk Institute; and Senior Scientific Executive at National Institutes of Health. Stefano studied at Johns Hopkins University between 2009 and 2011 and Università Cattolica between 1991 and 1995.

Randel S. Marfin is a Chief Executive Officer at Biophysical Society and is based in United States. She works or has worked at Damon Clinical Laboratories and SPECTRACELL LABORATORIES INC. Randel studied at University of Houston.

Thomas Kallstrom is a Chief Executive Officer/Executive Director at American Association for Respiratory Care (AARC) and is based in American Association for Respiratory Care. He has worked as COO at American Association for Respiratory Care (AARC), RT Director at Fairview Hospital, and Department Manager at RAINBOW BABIES & CHILDREN'S.

Charis Zhou MHA MPH is a Chief Executive Officer at American Public Health Association and Founder & CEO at Healthy China☯️ ��=Healthy World Media Co. and is based in Gatineau, Quebec, Canada. She has worked as Research Assistant at American Public Health Association, Reviewer of Medical Care at WOLTERS KLUWER HEALTH, and Researcher (Graduate Student) at Université de Montréal. Charis attended Université de Montréal between 2005 and 2009, Sun Yat sen University between 1994 and 1997, and Xinjiang Medical University between 1987 and 1992.